August 2024, Vol 5, No. 8

JAMA Forum

Better Data to Improve Medicaid

Heidi Allen, PhD; Katherine Baicker, PhD

Abstract Full Text

open access

JAMA Health Forum. 2024;5(8):e242953. doi:10.1001/jamahealthforum.2024.2953

This JAMA Forum discusses the current data collection mechanisms used for Medicare and proposes ways to improve nationwide data collection efforts for Medicaid.

What Can Be Learned From Nonadherent Patients to Promote the Health of Populations?

Sandro Galea, MD, DrPH

Abstract Full Text

open access

JAMA Health Forum. 2024;5(8):e243025. doi:10.1001/jamahealthforum.2024.3025

This JAMA Forum discusses patient- and population-level nonadherence to medical advice and elaborates on 4 main categories of reasons that underpin nonadherence.

The Pathology of US Health Care—The Example of Weight Loss Medications

David M. Cutler, PhD

Abstract Full Text

open access

JAMA Health Forum. 2024;5(8):e243052. doi:10.1001/jamahealthforum.2024.3052

This JAMA Forum discusses the cost of newly approved weight loss medications in the US compared with other countries and provides arguments for why these medications should be more available for individuals in the US and covered by more insurers.

Viewpoint

Reducing Disparities Through Online Accessibility Information

Benjamin A. Barsky, JD, MBE; Michael Ashley Stein, JD, PhD; Lisa I. Iezzoni, MD, MSc

Abstract Full Text

open access

JAMA Health Forum. 2024;5(8):e241801. doi:10.1001/jamahealthforum.2024.1801

This Viewpoint describes the need for more health care organizations to include disability accessibility information on their websites and to improve physical access for patients with disabilities.

Insights From a New National Academies Report on Caregiving

Reshma Jagsi, MD, DPhil; Robert Phillips, MD, MSPH; Elena Fuentes-Afflick, MD, MPH

Abstract Full Text

open access

JAMA Health Forum. 2024;5(8):e241925. doi:10.1001/jamahealthforum.2024.1925

This Viewpoint details the findings of a report from the National Academies of Sciences, Engineering, and Medicine on family caregiving among those in science, technology, engineering, mathematics, and medicine.

Expanding Treatment Options for Alcohol Use Disorder

Lori Uscher-Pines, PhD; Kevin Lin, BA; Alisa B. Busch, MD

Abstract Full Text

open access

JAMA Health Forum. 2024;5(8):e242184. doi:10.1001/jamahealthforum.2024.2184

This Viewpoint discusses the emergence of telemedicine as a potential treatment option for alcohol use disorder and highlights the advantages, disadvantages, and barriers of this care model.

Original Investigation

Quality-of-Care Outcomes in Vertical Relationships Between Physicians and Health Systems

Katherine M. Ianni, BA; Anna D. Sinaiko, PhD; Vilsa E. Curto, PhD; et al.

Abstract Full Text

open access

JAMA Health Forum. 2024;5(8):e242173. doi:10.1001/jamahealthforum.2024.2173

This difference-in-differences study explores the association of vertical relationships between primary care physicians and large health systems regarding quality of care.

Practice Facilitation to Address Unhealthy Alcohol Use in Primary Care: A Cluster Randomized Clinical Trial

Alison N. Huffstetler, MD; Gabriela Villalobos, MSW; Ben Webel, BA; et al.

Abstract Full Text

open access

JAMA Health Forum. 2024;5(8):e242371. doi:10.1001/jamahealthforum.2024.2371

This cluster randomized clinical trial aims to determine if tailored practice facilitation improved rates of recommended screening and management of unhealthy alcohol use compared to usual care.

Macular Degeneration Drug Prescribing Patterns After Step Therapy Introduction in Medicare Advantage

Angela Liu, PhD, MPH; Kelly E. Anderson, PhD, MPP; Joseph Levy, PhD; et al.

Abstract Full Text

open access

JAMA Health Forum. 2024;5(8):e242446. doi:10.1001/jamahealthforum.2024.2446

This retrospective encounter-based analysis evaluates the impact of step therapy on macular degeneration drug prescribing patterns among 3 large Medicare Advantage insurers.

Drug Prices After Patent Expirations in High-Income Countries and Implications for Cost-Effectiveness Analyses

Miquel Serra-Burriel, PhD; Nicolau Martin-Bassols, PhD; Gellért Perényi, MSc; et al.

Abstract Full Text

open access

JAMA Health Forum. 2024;5(8):e242530. doi:10.1001/jamahealthforum.2024.2530

This economic evaluation assesses drug price changes after patent expirations in 8 high-income countries and what the implications are for cost-effectiveness analyses.

Research Letter

Prescription Fills for Semaglutide Products by Payment Method

Christopher Scannell, MD, PhD; John Romley, PhD; Rebecca Myerson, PhD; et al.

Abstract Full Text

open access

JAMA Health Forum. 2024;5(8):e242026. doi:10.1001/jamahealthforum.2024.2026

This cross-sectional study examines trends in US prescription fills for semaglutide products by payment method between January 2021 and December 2023.

Brief Report

Safety Net Primary Care Capabilities After the COVID-19 Pandemic

Karen E. Schifferdecker, PhD, MPH; Ching-Wen W. Yang, MSPH; Matthew B. Mackwood, MD, MPH; et al.

Abstract Full Text

open access

JAMA Health Forum. 2024;5(8):e242547. doi:10.1001/jamahealthforum.2024.2547

This survey study compares post–COVID-19 pandemic operational characteristics and capabilities of federally qualified health centers with non–federally qualified health centers.

Special Communication

Advancing Health Policy and Outcomes for People With Intellectual or Developmental Disabilities: A Community-Led Agenda

Hoangmai H. Pham, MD, MPH; Teal W. Benevides, PhD, OTRL; May-Lynn Andresen, DNP, RN; et al.

Abstract Full Text

open access has active quiz

JAMA Health Forum. 2024;5(8):e242201. doi:10.1001/jamahealthforum.2024.2201

This Special Comunication proposes national goals based on a community-led consensus model to propose policy and clinical changes to improve outcomes that matter to people with intellectual and/or developmental disabilities.

Correction

Omitted Conflict of Interest Disclosures

Abstract Full Text

open access

JAMA Health Forum. 2024;5(8):e243106. doi:10.1001/jamahealthforum.2024.3106

July 2024 - January 2020

Decade

Year

Issue

August 2024, Vol 5, No. 8

Better Data to Improve Medicaid

What Can Be Learned From Nonadherent Patients to Promote the Health of Populations?

The Pathology of US Health Care—The Example of Weight Loss Medications

Reducing Disparities Through Online Accessibility Information

Insights From a New National Academies Report on Caregiving

Expanding Treatment Options for Alcohol Use Disorder

Quality-of-Care Outcomes in Vertical Relationships Between Physicians and Health Systems

Practice Facilitation to Address Unhealthy Alcohol Use in Primary Care: A Cluster Randomized Clinical Trial

Macular Degeneration Drug Prescribing Patterns After Step Therapy Introduction in Medicare Advantage

Drug Prices After Patent Expirations in High-Income Countries and Implications for Cost-Effectiveness Analyses

Prescription Fills for Semaglutide Products by Payment Method

Safety Net Primary Care Capabilities After the COVID-19 Pandemic

Advancing Health Policy and Outcomes for People With Intellectual or Developmental Disabilities: A Community-Led Agenda

Omitted Conflict of Interest Disclosures

JAMA Health Forum

Featured Articles

USPSTF Recommendation Statements

Blogs